
Glydorado 35mg Tablet
Marketer
El-Dorado Bio-Tech Pvt Ltd
Salt Composition
Glimepiride (35mg)
Overview Glydorado 35mg Tablet
Diabetace 35mg tablets, a sulfonylurea medication, manage type 2 diabetes in adults. It regulates blood glucose, mitigating serious diabetic complications like vision impairment and kidney failure. Diabetace 35mg may be prescribed alone or in combination with other therapies. Administer it with or immediately before your first daily meal, consistently at the same time for optimal effects. Dosage is determined by your physician and may be adjusted based on glucose monitoring. Continuous use of Diabetace 35mg is crucial, even with controlled blood sugar, as abrupt cessation can lead to dangerously elevated glucose levels and complications including nerve damage, limb loss, blindness, and kidney disease. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as recommended by your doctor. Lifestyle choices are paramount in diabetes control. Common side effects include hypoglycemia (low blood sugar), nausea, headaches, fatigue, and vertigo. Learn to recognize hypoglycemia symptoms (sweating, dizziness, tremors, headaches) and appropriate countermeasures, such as consuming readily available glucose (e.g., juice or sweets). Alcohol consumption elevates hypoglycemia risk and should be limited. Weight gain is a potential side effect. Diabetace 35mg is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your physician of any pre-existing conditions such as heart or thyroid disease, or hormonal disorders, prior to commencing treatment. Pregnant or lactating individuals should seek medical advice before using this medication. Regular blood glucose monitoring, along with periodic blood tests for liver function and blood cell counts, is essential.
Uses of Glydorado 35mg Tablet
Managing Type 2 Diabetes
Major Benefits of Glydorado 35mg Tablet:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the 35mg Glydorado tablet whole; avoid chewing, crushing, or breaking it. Consume this medicine with food.
Common Side effects of Glydorado 35mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Dizziness
- Weakness
How to use Glydorado 35mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Glydorado 35mg Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Consume with food.
How Glydorado 35mg Tablet works:
Pancreatic insulin secretion is stimulated by Glydorado 35mg tablets, a medication used to manage diabetes, thus reducing blood sugar levels.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Glydorado 35mg Tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Glydorado 35mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against any risks prior to prescribing this medication. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
Use of the 35mg Glydorado tablet while breastfeeding is likely inadvisable. Available human data indicate potential transfer to breast milk, posing a risk to the infant. Close observation of the nursing infant's blood sugar levels is recommended if the mother takes Glydorado 35mg tablets.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyCAUTION
Patients with impaired kidney function should use Glydorado 35mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Glydorado 35mg tablets are contraindicated in patients with severe kidney disease due to the risk of severe hypoglycemia, which may resolve over an extended period.
LiverCAUTION
Patients with liver impairment should use Glydorado 35mg tablets cautiously, potentially requiring dose modification. Physician consultation is advised. Glydorado 35mg tablets are contraindicated in patients with severe hepatic disease due to the risk of severe hypoglycemia, which may resolve only after an extended period.
What if you forget to take Glydorado 35mg Tablet :
Omit the forgotten Glydorado 35mg Tablet dose; resume your regular dosing schedule.
Facts to Know About Glydorado 35mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Advanced Sulfonylurea |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
